Advertisement

Topics

Search Results for "New Arthritis Medication 2012"

10:37 EDT 23rd May 2017 | BioPortfolio

Matching Channels

Matching News

Coping with arthritis: What you do isn't associated with how much information you want

(Bentham Science Publishers) Arthritis patients were more likely to be high monitors (health detail oriented) than high blunters (health detail avoidant) in a study led by the University of North Caro...

Registry study: Lymphoma risk for patients with rheumatoid arthritis remains increased

The risk for malignant lymphoma remained increased for patients with rheumatoid arthritis, according to recently published population-based data for 1997 to 2012. Karin Hellgren, MD, PhD, at the ...

Assay opens way to autoantibodies treatment for rheumatoid arthritis

A new discovery, conducted by researchers at the NYU Langone Medical Center and the University of Pittsburgh, has pointed towards a potential shift in the way that rheumatoid arthritis (RA) could be t...

A diagnosis of psoriatic arthritis led Pam Relph from the army to the Paralympics, just in time to win gold (twice)

Pam Relph’s heartbreak when she was medically discharged from the army due to psoriatic arthritis was rapidly followed by elation at finding herself on the British Paralympic rowing team, training f...

Psoriatic arthritis was associated with osteoporosis, ankylosing spondylitis

Investigators of this cross-sectional study found psoriasis and psoriatic arthritis correlated with pathologic fractures and other bone-related conditions. Johnathan I. Silverberg , MD...

FDA extends review period for rheumatoid arthritis treatment Baricitinib

Eli Lilly and Incyte announced that the FDA has extended the review period for the new drug application (NDA) for investigational baricitinib, a once-daily oral medication for the treatment of moderat...

Rheumatoid Arthritis Drug May Not Ease Chronic Fatigue Syndrome After All

MONDAY, March 6, 2017 -- A small-scale clinical trial has cast doubt upon the potential usefulness of an anti-inflammatory drug to treat chronic fatigue syndrome. Doctors had hoped that anakinra (Kine...

CFDA Approves Pfizer Oral Arthritis Treatment for China Use

Pfizer has received permission from the CFDA to market an oral treatment for rheumatoid arthritis in China. Xeljanz® (tofacitinib citrate), a Janus kinase inhibitor, is indicated for adult patient...

Matching PubMed Articles

Associations Between Patient Characteristics and the Amount of Arthritis Medication Information Patients Receive.

Little is known about factors associated with the receipt of medication information among arthritis patients. This study explores information source receipt and associations between demographic and cl...

Medication adherence in patients with rheumatoid arthritis: why do patients not take what we prescribe?

Rheumatoid arthritis (RA) is an autoimmune inflammatory disease which results in extensive articular and extra-articular morbidity and increased mortality from cardiovascular disease. Despite an incre...

Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions.

Self-injectable TNF inhibitors are increasingly used early in the chronic treatment of moderate to severe rheumatologic conditions. We estimated medication adherence/persistence over time following in...

Medication Knowledge Among Older Adults Admitted to Home Care in Ontario During 2012-2013.

Medication use among Canadian seniors is widespread and increases with the number of comorbidities. Limited evidence exists on medication knowledge among seniors, especially in home care.

Medication Non-Adherence in Systemic Lupus Erythematosus: A Systematic Review.

Medication non-adherence has not been well characterized in systemic lupus erythematosus (SLE). Our objective was to a conduct a systematic review of the literature examining the burden and determinan...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement